Suggestions
Chris Dimitropoulos
Managing Director, Biotechnology Investments (Private & Public) at FALCON EDGE CAPITAL, LP
Chris Dimitropoulos is a highly experienced biotech investor, executive, and entrepreneur with a career spanning around 20 years.
He is dedicated to supporting biotech therapeutics companies in their mission to develop medicines that enhance the well-being of patients in need.
Chris holds a Master of Science (MS) degree in Biotechnology from The Johns Hopkins University and has pursued studies at the University of Illinois Urbana-Champaign.
His professional journey includes notable roles such as Managing Director of Biotechnology Investments at FALCON EDGE CAPITAL, LP.
He was also the CEO and Co-Founder of Inexos Therapeutics, and has held positions like Portfolio Manager at J. Goldman & Co., L.P., Portfolio Manager - Carve-Out at Millennium Partners, and VP at Astor Group.
Chris Dimitropoulos has a background as a Hedge Fund Biotech Equities Analyst at Citadel and as a Biotech Equities Associate Analyst at J.P. Morgan.
